Health System Builds Telehealth Network; Sees Great Return on Investment

Source: Healthcare Finance News, Erin McCann (5/22/12)

"Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania."

Healthcare Finance News, Erin McCann

Bluetooth-capable stethoscopes, allowing doctors to hear heart sounds from across the country, are just one innovation Saint Vincent Health System is using in its new telehealth network, which has reduced hospital readmissions and generated a 100 percent ROI in less than two months, officials say.

Pleasanton, Calif.-based Polycom, a video conference and communications company, is helping Saint Vincent Health System build a telehealth network with technology that seeks to make healthcare more accessible by visually connecting healthcare professionals and patients in virtual environments across 26 facilities in Pennsylvania. . .View Full Article

Cleantech Co. Advances Antimicrobial Wound Care Breakthrough
Source: Streetwise Reports (10/17/2025)

Cleantech innovation company BioLargo Inc. (BLGO:OTCQX) announced that subsidiary Clyra Medical Technologies is making significant strides. Read why one analyst says the technology is on "the cusp of commercialization."

Biotech Battles FDA, Target Price Shows Potential 90% Gains
Source: Dr. Boobalan Pachaiyappan (10/01/2025)

Capricor Therapeutics Inc. (CAPR:NASDAQ) has recently been involved in a "tug-of-war with the FDA." Read on to see why one Roth analyst still rates this stock as a Buy.

AI Healthcare Stock Showing Signs of a Base Breakout
Source: John Newell (08/25/2025)

John Newell of John Newell & Associates explains why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.

Co.'s Graphene Used in New Screening Test for Lung Cancer
Source: Streetwise Reports (08/18/2025)

HydroGraph Clean Power Inc.'s (HG:CSE; HGRAF:OTCQB; M98:FSE) patented, high-purity material has applications in healthcare, as in this case, but also in numerous other industries. Read on to learn why some experts say this company could be a future 100-bagger.

Biotech Firm Adjusts Placement Terms to Fuel U.S. Expansion
Source: Streetwise Reports (07/07/2025)

Canadian healthcare and clinical stage drug development company Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) updates the pricing and warrant terms for its previously announced non-brokered private placement. Read why one technical analyst thinks the stock is ready to break out.